Novartis India [NOVARTIND] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Novartis India Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Novartis India Ltd. wins in 16 metrics, Sun Pharma Advanced Research Company Ltd. wins in 2 metrics, with 0 ties. Novartis India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Novartis India Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 25.00 -13.65 Novartis India Ltd.
Price-to-Book Ratio 3.14 -13.55 Novartis India Ltd.
Debt-to-Equity Ratio 0.52 -1.21 Novartis India Ltd.
PEG Ratio -1.18 -11.15 Novartis India Ltd.
EV/EBITDA 20.21 -22.27 Novartis India Ltd.
Profit Margin (TTM) 27.97% -53.22% Novartis India Ltd.
Operating Margin (TTM) 25.47% -700.71% Novartis India Ltd.
EBITDA Margin (TTM) 25.47% N/A N/A
Return on Equity 12.85% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 10.65% -102.08% Novartis India Ltd.
Free Cash Flow (TTM) $745.70M $-3.71B Novartis India Ltd.
Dividend Yield 2.44% N/A N/A
1-Year Return 49.33% 14.56% Novartis India Ltd.
Price-to-Sales Ratio (TTM) 7.00 87.98 Novartis India Ltd.
Enterprise Value $18.37B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 5.29 95.73 Novartis India Ltd.
Gross Profit Margin (TTM) 43.07% -59.53% Novartis India Ltd.
Revenue per Share (TTM) $141 $2 Novartis India Ltd.
Earnings per Share (Diluted) $39.42 $-8.25 Novartis India Ltd.
Beta (Stock Volatility) -0.05 0.19 Novartis India Ltd.

Novartis India Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

NOVARTIND
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Novartis India Ltd.-9.47%-10.87%29.78%44.07%63.91%70.30%
Sun Pharma Advanced Research Company Ltd.2.09%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Novartis India Ltd.49.33%115.71%137.09%117.42%110.10%222.44%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Novartis India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricNOVARTINDSPARC
Market Information
Market Cap i₹23.65B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i10,6932,401,062
90 Day Avg. Volume i14,0372,083,443
Last Close₹1,326.20₹208.50
52 Week Range₹750.00 - ₹1,588.40₹108.00 - ₹248.75
% from 52W High-16.51%-16.18%
All-Time High₹1,588.40 (Jun 01, 2026)₹875.00 (Apr 24, 2006)
% from All-Time High-16.51%-76.17%
Growth Metrics
Quarterly Revenue Growth-0.08%-0.43%
Quarterly Earnings Growth-0.37%-0.43%
Financial Health
Profit Margin (TTM) i0.28%-0.53%
Operating Margin (TTM) i0.25%-7.01%
Return on Equity (TTM) i0.13%1.58%
Debt to Equity (MRQ) i0.52-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹313.93₹-10.63
Cash per Share (MRQ)₹250.14₹0.03
Operating Cash Flow (TTM) i₹997.00M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹1.01B₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i2.44%N/A
Last 12-Month Dividend i₹25.00N/A

Valuation & Enterprise Metrics Analysis: Novartis India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricNOVARTIND (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i25.00-13.65
Forward P/E iN/A2.60
PEG Ratio i-1.18-11.15
Price to Sales (TTM) i7.0087.98
Price to Book (MRQ) i3.14-13.55
Market Capitalization
Market Capitalization i₹23.65B₹46.75B
Enterprise Value i₹18.37B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i5.2995.73
Enterprise to EBITDA i20.21-22.27
Risk & Other Metrics
Beta i-0.050.19
Book Value per Share (MRQ) i₹313.93₹-10.63

Financial Statements Comparison: Novartis India Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNOVARTIND (2025)SPARC (2025)
Revenue/Sales i3.56B717.66M
Cost of Goods Sold i2.06B1.10B
COGS % of Revenue i57.7%153.2%
Gross Profit i1.51B-381.94M
Gross Margin i42.3%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i941.70M-3.34B
Operating Margin i26.4%-465.5%
EBITDA i1.38B-3.23B
EBITDA Margin i38.7%-450.0%
Pre-Tax Income i1.30B-3.43B
Pre-Tax Income % of Revenue i36.6%-477.6%
Income Tax i295.20M-2.72M
Income Tax % of Revenue i8.3%-0.4%
Net Income (Profit) i1.01B-3.43B
Profit Margin i28.3%-477.3%

Balance Sheet & Liquidity Metrics

MetricNOVARTIND (2025)SPARC (2025)
Cash & Equivalents i520.70M19.64M
Total Current Assets i7.46B261.97M
Total Current Assets % of Revenue i209.3%36.5%
Total Current Liabilities i1.42B3.74B
Total Current Liabilities % of Revenue i39.9%521.5%
Long-Term Debt i32.10M1.07B
Long-Term Debt % of Revenue i0.9%149.0%
Total Shareholders Equity i7.85B-2.17B
Retained Earnings i7.69B-23.22B
Retained Earnings % of Revenue i215.8%-3,235.0%
Property, Plant & Equipment i35.70M178.02M

Cash Flow Statement Comparison

MetricNOVARTIND (2025)SPARC (2025)
Operating Cash Flow i997.00M-3.48B
Operating Cash Flow % of Revenue i28.0%-485.5%
Capital Expenditures i3.20M-97.45M
Free Cash Flow i745.70M-3.71B
FCF Margin i20.9%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNOVARTINDSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i24.69M324.52M
Float Shares i6.69M91.32M
% Held by Insiders i72.92%72.96%
% Held by Institutions i0.16%2.56%
% Held by Public i26.92%24.48%

Dividend Analysis & Yield Comparison: Novartis India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricNOVARTINDSPARC
Last 12-Month Dividend i₹25.00N/A
Last 12-Month Dividend Yield i2.44%N/A
3-Year Avg Annual Dividend i₹32.50N/A
3-Year Avg Dividend Yield i3.57%N/A
3-Year Total Dividends i₹97.50N/A
Ex-Dividend DateJul 23, 2025N/A